Cleared Traditional

K023723 - FINOMETER NONINVASIVE HEMODYNAMIC MONITOR, MODEL 1

K023723 is an FDA 510(k) clearance for FINOMETER NONINVASIVE HEMODYNAMIC MONITOR, manufactured by Fms, Finapres Medical Systems BV. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 352-day FDA review.

K023723 · Fms, Finapres Medical Systems BV · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2003
Decision
352d
Days
Class 2
Risk

K023723 is an FDA 510(k) clearance for the FINOMETER NONINVASIVE HEMODYNAMIC MONITOR, MODEL 1. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Fms, Finapres Medical Systems BV (Santa Barbara, US). The FDA issued a Cleared decision on October 23, 2003 after a review of 352 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Fms, Finapres Medical Systems BV devices

FDA 510(k) Submission Details - K023723

510(k) Number K023723 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 05, 2002
Decision Date October 23, 2003
Days to Decision 352 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
227d slower than avg
Panel avg: 125d · This submission: 352d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 905
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K023723.
OMRON INTELLISENSE DIGITAL BLOOD PRESSURE MONITOR, MODEL HEM-907XL
K032305 · Omron Healthcare, Inc. · Feb 2004
ZOLL M SERIES NIBP OPTION
K032363 · Zoll Medical Corp · Oct 2003
A & D MEDICAL LIFESOURCE UA-704 DIGITAL BLOOD PRESSURE MONITORS
K032499 · A&D Engineering, Inc. · Oct 2003
HL888BM
K032837 · Health & Life Co., Ltd. · Oct 2003
HL888BA
K032839 · Health & Life Co., Ltd. · Oct 2003
MODIFICATION TO HL168
K033043 · Health & Life Co., Ltd. · Oct 2003